Tredje AP-fonden’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-27,000
Closed -$19.2M 473
2024
Q4
$19.2M Hold
27,000
0.17% 104
2024
Q3
$28.4M Hold
27,000
0.26% 78
2024
Q2
$28.4M Hold
27,000
0.27% 75
2024
Q1
$26M Buy
27,000
+22,362
+482% +$21.5M 0.27% 81
2023
Q4
$4.07M Sell
4,638
-43,469
-90% -$38.2M 0.05% 228
2023
Q3
$39.6M Sell
48,107
-722
-1% -$594K 0.58% 40
2023
Q2
$35.1M Buy
48,829
+119
+0.2% +$85.5K 0.5% 45
2023
Q1
$40M Buy
48,710
+20,861
+75% +$17.1M 0.62% 35
2022
Q4
$20.1M Buy
27,849
+1,603
+6% +$1.16M 0.34% 75
2022
Q3
$18.1M Buy
26,246
+17,194
+190% +$11.8M 0.37% 65
2022
Q2
$5.35M Hold
9,052
0.13% 144
2022
Q1
$6.32M Hold
9,052
0.13% 142
2021
Q4
$5.72M Hold
9,052
0.11% 156
2021
Q3
$5.48M Hold
9,052
0.11% 150
2021
Q2
$5.06M Hold
9,052
0.1% 123
2021
Q1
$4.28M Hold
9,052
0.1% 136
2020
Q4
$4.37M Hold
9,052
0.11% 134
2020
Q3
$5.07M Hold
9,052
0.16% 96
2020
Q2
$5.65M Sell
9,052
-6,174
-41% -$3.85M 0.23% 81
2020
Q1
$7.44M Sell
15,226
-521
-3% -$254K 0.39% 60
2019
Q4
$5.91M Sell
15,747
-946
-6% -$355K 0.3% 78
2019
Q3
$4.63M Buy
16,693
+118
+0.7% +$32.7K 0.22% 117
2019
Q2
$5.19M Buy
16,575
+741
+5% +$232K 0.25% 93
2019
Q1
$6.5M Buy
15,834
+1,065
+7% +$437K 0.34% 72
2018
Q4
$5.52M Sell
14,769
-10,200
-41% -$3.81M 0.34% 71
2018
Q3
$10.1M Sell
24,969
-2,559
-9% -$1.03M 0.49% 46
2018
Q2
$9.5M Buy
27,528
+1,430
+5% +$493K 0.33% 86
2018
Q1
$8.99M Buy
26,098
+779
+3% +$268K 0.32% 77
2017
Q4
$9.52M Sell
25,319
-50
-0.2% -$18.8K 0.32% 73
2017
Q3
$11.3M Buy
25,369
+790
+3% +$353K 0.4% 57
2017
Q2
$12.1M Sell
24,579
-110
-0.4% -$54K 0.45% 49
2017
Q1
$9.57M Buy
24,689
+44
+0.2% +$17.1K 0.38% 66
2016
Q4
$9.05M Sell
24,645
-196
-0.8% -$72K 0.38% 60
2016
Q3
$9.99M Sell
24,841
-759
-3% -$305K 0.45% 52
2016
Q2
$8.94M Buy
25,600
+5
+0% +$1.75K 0.4% 56
2016
Q1
$9.52M Buy
25,595
+2,132
+9% +$793K 0.43% 56
2015
Q4
$12.7M Buy
23,463
+18,758
+399% +$10.2M 0.82% 29
2015
Q3
$2.19M Sell
4,705
-513
-10% -$239K 0.21% 122
2015
Q2
$2.66M Buy
+5,218
New +$2.66M 0.21% 125